Cadila Pharmaceuticals, one of the country's largest privately-held drug manufacturers, has won the “Rising Digital Star of the Year” award for its Blend Marketing Campaign at the prestigious DigipharmaX Marketing Awards 2022.

The Pharmax Awards are widely acknowledged by the pharmaceutical industry as the highest accolades available to companies in the industry, as recognized in the India region.

The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks. The company used all leading social media platforms to merge multi-channel marketing to maximise its digital approach.

The campaign was focused on new market development, customer segmentation, and differentiation from competition, and produced excellent results. Through the campaign the company could reach over 950 customers across 70 cities.

Cadila Pharmaceuticals continue to offer cutting-edge wellness solutions to the global health care needs, and are steadfastly committed to our vision of providing highest quality, affordable and innovative solutions in medicine and treatment.

Speaking about the award Jawed Zia – CEO, Cadila Pharmaceuticals said, “We are thrilled to be receiving the Rising Digital Star of the Year award. Social media is playing an increasingly vital role in communication, and we are committed to making the most of social media’s power and reach.”